New meningococcal vaccine recommendations under consideration

Journal of American College Health

Volumn 53, Issue 2, 2004, Pages 89-91

  Turner, James C ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Amer Coll Hlth Assoc Task F   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA VACCINE; ISONIAZID; MEASLES VACCINE; MENINGOCOCCUS VACCINE; MUMPS VACCINE; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE; RUBELLA VACCINE; TETANUS TOXOID;

B LYMPHOCYTE; COST BENEFIT ANALYSIS; HEALTH CARE DELIVERY; HEALTH PRACTITIONER; HEALTH SERVICE; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; MENINGOCOCCOSIS; MORBIDITY; RISK ASSESSMENT; SHORT SURVEY; T LYMPHOCYTE; VACCINATION;

EID: 4944264522     PISSN: 07448481     EISSN: None     Source Type: Journal    
DOI: 10.3200/JACH.53.2.89-92     Document Type: Short Survey

References (5)

1. Granoff DM, Feavers IM, Borrow R. Meningococcal vaccines. In: Plotkin SA, Orenstein WA, eds. Vaccines. 4th ed. Philadelphia: WB Saunders Co; 2004:973-977.
2. Center for Disease Control and Prevention. Prevention and Control of Meningococcal Disease and Meningococcal Disease and College Students. Recommendations or the Advisory Committee on Immunization Practices. MMWR. 2000;49 (No. RR-7):16-17.
3. Shepard C. Cost effectiveness of conjugate meningococcal vaccine strategies in the United States. Paper presented at: ACIP meeting; June 24, 2004; Atlanta, GA.
4. Lieu TA, Ray GT, Black SB, et al. Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children. JAMA. 2000;283(11):1460-1468.
5. Tengs TO, Adams ME, Plishin JS, et al. Five hundred life-saving interventions and their cost-effectiveness. Risk Analysis. 1995;15:369-390.